Company / Capital Returned to Shareholders
Globus Medical Capital Returned to Shareholders History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$300.5M
FY2025
5-year range
$85.8M / $300.5M
FY2021-FY2025
Trend
+250.2%
vs FY2024
Sector context
#44 of 108
Health Care
What the data says
Capital Returned to Shareholders changed +250% YoY in FY2025, a notable deviation from the 5-year average annual change of +56%.
Based on SEC 10-K filings.
$300M in FY2025 with a 5-year CAGR of +23.5%.
Improved from $226M to $300M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +27.6%
- 5-Year CAGR
- +23.5%
- 10-Year CAGR
- -
Sector benchmark
#44 of 108 in Health CareTop 41% of 108This company $300.5M Sector average $744.4M
▼
-59.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.5%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 250.2% year-over-year.
- Ranks #44 out of 108 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $300.5M | +250.2% |
| FY2024 | $85.8M | -62.0% |
| FY2023 | $225.6M | +56.1% |
| FY2022 | $144.5M | +38.0% |
| FY2021 | $104.7M | +0.0% |
| FY2020 | $104.7M | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026